Gastrodin ameliorates depressive-like behaviors and up-regulates the expression of BDNF in the hippocampus and hippocampal-derived astrocyte of rats

Neurochemical Research

Volumn 39, Issue 1, 2014, Pages 172-179

  Zhang, Ruiguo ^a   Peng, Zhengwu ^a,b   Weng, Huaihai ^a   Xue, Fen ^a   Chen, Yihuan ^a   Wang, Ying ^a   Wang, Huaning ^a   Tan, Qingrong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Astrocyte; BDNF; Depression; Gastrodin; Hippocampus

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; GASTRODIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; ASTROCYTE; CELL VIABILITY; CHRONIC UNPREDICTABLE STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; FORCED SWIM TEST; HIPPOCAMPUS; IN VITRO STUDY; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STRESS; SUCROSE PREFERENCE TEST; UPREGULATION;

RATTUS;

ANIMALS; ANTIDEPRESSIVE AGENTS; ASTROCYTES; BEHAVIOR, ANIMAL; BENZYL ALCOHOLS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSIVE DISORDER; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSIDES; HELPLESSNESS, LEARNED; HIPPOCAMPUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; STRESS, PSYCHOLOGICAL; UP-REGULATION;

EID: 84892680000     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1203-0     Document Type: Article

References (37)

1. Gibson TB, Jing Y, Smith Carls G, Kim E, Bagalman JE, Burton WN, Tran QV, Pikalov A, Goetzel RZ (2010) Cost burden of treatment resistance in patients with depression. Am J Manag Care 16:370-377
2. Leucht C, Huhn M, Leucht S (2012) Amitriptyline versus placebo for major depressive disorder. Cochrane Database Syst Rev 12: CD009138
3. Murata A, Kanbayashi T, Shimizu T, Miura M (2012) Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement. Patient Prefer Adherence 6:863-869
4. Berlim MT, Turecki G (2007) Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 52:46-54 (Pubitemid 46743497)
5. Brent DA, Birmaher B (2006) Treatment-resistant depression in adolescents: recognition and management. Child Adolesc Psychiatr Clin N Am 15:1015-1034 (Pubitemid 44307685)
6. Ojemann LM, Nelson WL, Shin DS, Rowe AO, Buchanan RA (2006) Tian ma, an ancient Chinese herb, offers new options for the treatment of epilepsy and other conditions. Epilepsy Behav 8:376-383 (Pubitemid 43231229)
7. Lin LC, Chen YF, Lee WC, Wu YT, Tsai TH (2008) Pharmacokinetics of gastrodin and its metabolite p-hydroxybenzyl alcohol in rat blood, brain and bile by microdialysis coupled to LC-MS/MS. J Pharm Biomed Anal 48:909-917
8. Xu X, Lu Y, Bie X (2007) Protective effects of gastrodin on hypoxia-induced toxicity in primary cultures of rat cortical neurons. Planta Med 73:650-654 (Pubitemid 47066157)
9. Zhao X, Zou Y, Xu H, Fan L, Guo H, Li X, Li G, Zhang X, Dong M (2012) Gastrodin protect primary cultured rat hippocampal neurons against amyloid-beta peptide-induced neurotoxicity via ERK1/2-Nrf2 pathway. Brain Res 1482:13-21
10. Zeng X, Zhang S, Zhang L, Zhang K, Zheng X (2006) A study of the neuroprotective effect of the phenolic glucoside gastrodin during cerebral ischemia in vivo and in vitro. Planta Med 72:1359-1365 (Pubitemid 46102388)
11. Dai JN, Zong Y, Zhong LM, Li YM, Zhang W, Bian LG, Ai QL, Liu YD, Sun J, Lu D (2011) Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS ONE 6:e21891
12. Jung JW, Yoon BH, Oh HR, Ahn JH, Kim SY, Park SY, Ryu JH (2006) Anxiolytic-like effects of Gastrodia elata and its phenolic constituents in mice. Biol Pharm Bull 29:261-265 (Pubitemid 43200893)
13. Hsieh MT, Wu CR, Chen CF (1997) Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J Ethnopharmacol 56:45-54 (Pubitemid 27182742)
14. Yong W, Xing TR, Wang S, Chen L, Hu P, Li CC, Wang HL, Wang M, Chen JT, Ruan DY (2009) Protective effects of gastrodin on lead-induced synaptic plasticity deficits in rat hippocampus. Planta Med 75:1112-1117
15. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119:7-35
16. Ridet JL, Malhotra SK, Privat A, Gage FH (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20:570-577 (Pubitemid 27508969)
17. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127
18. Castren E, Voikar V, Rantamaki T (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18-21 (Pubitemid 46238033)
19. Koo JW, Duman RS (2008) IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A 105:751-756 (Pubitemid 351171780)
20. Slattery DA, Cryan JF (2012) Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat Protoc 7:1009-1014
21. Zhu H, Chen MF, Yu WJ, Wang WJ, Li F, Liu WC, Wo Y, Xia R, Ding WL (2012) Time-dependent changes in BDNF expression of pentylenetetrazole-induced hippocampal astrocytes in vitro. Brain Res 1439:1-6
22. Banasr M, Valentine GW, Li XY, Gourley SL, Taylor JR, Duman RS (2007) Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 62:496-504 (Pubitemid 47284039)
23. Anisman H, Matheson K (2005) Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 29:525-546 (Pubitemid 40755455)
24. Fellin T (2009) Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity. J Neurochem 108:533-544
25. Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T (2007) Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 12:167-189 (Pubitemid 46160982)
26. Sillaber I, Panhuysen M, Henniger MS, Ohl F, Kuhne C, Putz B, Pohl T, Deussing JM, Paez-Pereda M, Holsboer F (2008) Profiling of behavioral changes and hippocampal gene expression in mice chronically treated with the SSRI paroxetine. Psychopharmacology 200:557-572
27. Allaman I, Fiumelli H, Magistretti PJ, Martin JL (2011) Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology 216:75-84
28. Hisaoka K, Takebayashi M, Tsuchioka M, Maeda N, Nakata Y, Yamawaki S (2007) Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. J Pharmacol Exp Ther 321:148-157 (Pubitemid 46456986)
29. Deltheil T, Guiard BP, Cerdan J, David DJ, Tanaka KF, Reperant C, Guilloux JP, Coudore F, Hen R, Gardier AM (2008) Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology 55:1006-1014
30. Czubak A, Nowakowska E, Kus K, Burda K, Metelska J, Baer-Dubowska W, Cichocki M (2009) Influences of chronic venlafaxine, olanzapine and nicotine on the hippocampal and cortical concentrations of brain-derived neurotrophic factor (BDNF). Pharmacol Rep 61:1017-1023
31. Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA, Duan W (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp Neurol 210:154-163
32. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261 (Pubitemid 35379212)
33. Paizanis E, Renoir T, Lelievre V, Saurini F, Melfort M, Gabriel C, Barden N, Mocaer E, Hamon M, Lanfumey L (2010) Behavioural and neuroplastic effects of the new-generation antidepressant agomelatine compared to fluoxetine in glucocorticoid receptor-impaired mice. Int J Neuropsychopharmacol 13:759-774
34. Massa SM, Yang T, Xie Y, Shi J, Bilgen M, Joyce JN, Nehama D, Rajadas J, Longo FM (2010) Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 120:1774-1785
35. Duric V, Banasr M, Licznerski P, Schmidt HD, Stockmeier CA, Simen AA, Newton SS, Duman RS (2010) A negative regulator of MAP kinase causes depressive behavior. Nat Med 16:1328-1332
36. Di Benedetto B, Kuhn R, Nothdurfter C, Rein T, Wurst W, Rupprecht R (2012) N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant. Neuropharmacology 62:209-216
37. Li B, Zhang S, Li M, Hertz L, Peng L (2009) Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology 207:1-12